Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a ...

Keymed Biosciences Inc. (HKEX: 02162) announced its annual results of 2024, along with a corporate update. Rapid de ...

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...

根据 T2T 概念，瘙痒的最佳 6 个月治疗目标是患者报告的峰值瘙痒数字评定量表（Peak Pruritus Numeric Rating Scale，PP-NRS）评分≤4 分。 那么，在实际治疗中，这些 “小目标” 能否实现呢？来自多个国家研究机构的研究人员，如德国明斯特大学医院皮肤科、美国 ...

注：年龄＜18岁青少年受试者体重需≥30kg。 2、AD受累程度同时符合以下标准：a）筛选时患病时间≥1年；b）IGA评分≥3；EASI评分≥16；AD受累面积BSA≥10%；每日PP-NRS评分的周平均值≥4分；3）经研究者判断，受试者对皮质类固醇（TCS）等外用药物疗效不佳或不适宜 ...